Tender

QUB/2485/23 Contract for for a Compact Multi-modal and Multi-scale Retinal Imaging System

  • Queens University Belfast

F02: Contract notice

Notice identifier: 2024/S 000-002640

Procurement identifier (OCID): ocds-h6vhtk-0434ab

Published 25 January 2024, 4:36pm



Section one: Contracting authority

one.1) Name and addresses

Queens University Belfast

University Road

Belfast

BT7 1NN

Contact

Shauna Ryan

Email

Shauna.Ryan@qub.ac.uk

Country

United Kingdom

NUTS code

UKN06 - Belfast

Internet address(es)

Main address

www.qub.ac.uk

Buyer's address

https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

https://in-tendhost.co.uk/queensuniversitybelfast/aspx/Home

Tenders or requests to participate must be submitted to the above-mentioned address

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Education


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

QUB/2485/23 Contract for for a Compact Multi-modal and Multi-scale Retinal Imaging System

Reference number

QUB/2485/23

two.1.2) Main CPV code

  • 33110000 - Imaging equipment for medical, dental and veterinary use

two.1.3) Type of contract

Supplies

two.1.4) Short description

Multiple research groups within QUB are addressing the earliest changes of disease at the complex intersection between normal ageing and early pathology in AMD (Peto, Hogg, Lengyel), Diabetic Retinopathy (Peto, Stitt, Lois, Hogg, Curtis) and Glaucoma (Azuara-Blanco and Hogg), exploring interventions to delay or prevent onset. Cutting edge retinal imaging is crucial to these endeavours. Advanced retinal imaging has been at the forefront of research advances in ophthalmology; as resolution has increased, the capacity to understand disease mechanisms has advanced for all major blinding conditions. In the retina, this has advanced on two parallel fronts, firstly, improved imaging of individual retinal layers including the photoreceptor mosaic, and secondly, improved imaging of retinal vasculature and microvasculature and associated structures. At the forefront of this is the ultra-high resolution provided by adaptive optics techniques, enabling single cell resolution in vivo. To date, th

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.2) Additional CPV code(s)

  • 33110000 - Imaging equipment for medical, dental and veterinary use
  • 33000000 - Medical equipments, pharmaceuticals and personal care products
  • 33100000 - Medical equipments

two.2.3) Place of performance

NUTS codes
  • UKN06 - Belfast

two.2.4) Description of the procurement

Multiple research groups within QUB are addressing the earliest changes of disease at the complex intersection between normal ageing and early pathology in AMD (Peto, Hogg, Lengyel), Diabetic Retinopathy (Peto, Stitt, Lois, Hogg, Curtis) and Glaucoma (Azuara-Blanco and Hogg), exploring interventions to delay or prevent onset. Cutting edge retinal imaging is crucial to these endeavours. Advanced retinal imaging has been at the forefront of research advances in ophthalmology; as resolution has increased, the capacity to understand disease mechanisms has advanced for all major blinding conditions. In the retina, this has advanced on two parallel fronts, firstly, improved imaging of individual retinal layers including the photoreceptor mosaic, and secondly, improved imaging of retinal vasculature and microvasculature and associated structures. At the forefront of this is the ultra-high resolution provided by adaptive optics techniques, enabling single cell resolution in vivo. To date, these various technologies are available at QUB to support clinical trials on separate instruments, necessitating long tiring visits for patients and challenges for researchers in co-registering the different imaging types to look at the same location simultaneously. In order to address some of the above issues, Queens University wishes to procure a compact, multi-modal and multi-scale retinal imaging system, with microscopic resolution capability that is able to overcome the above-mentioned issues, in combination with laser-based imaging to help with media opacities and provide confocality.The equipment will be installed at The Wellcome Trust-Wolfson Northern Ireland Clinical Research Facility (NICRF), a joint venture between Health and Social Care, Queens University, and the University of Ulster, located in Belfast City Hospital.

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

120

This contract is subject to renewal

Yes

Description of renewals

Option to extend maintenance and the purchase of consumables beyond this period for a further period of up to 10 years or the end of useful life of the equipment.

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: Yes

Description of options

Option to extend maintenance and the purchase of consumables beyond this period for a further period of up to 10 years or the end of useful life of the equipment.

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions

N/A

three.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

Accelerated procedure

Justification:

Queen's will be availing of Article 27 (3), Public Contracts Regulations 2015; where a state of urgency duly substantiated by the contracting authority renders impracticable the time limit laid down in the second subparagraph of paragraph 1, it may fix a time limit which shall be not less than 15 days from the date on which the contract notice was sent

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Date

9 February 2024

Local time

4:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.7) Conditions for opening of tenders

Date

9 February 2024

Local time

4:10pm

Place

Belfast


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.2) Information about electronic workflows

Electronic ordering will be used

Electronic invoicing will be accepted

Electronic payment will be used

six.4) Procedures for review

six.4.1) Review body

Queens University Belfast

Belfast

Country

United Kingdom

six.4.3) Review procedure

Precise information on deadline(s) for review procedures

N/A